Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Nobiletin, a polymethoxyflavone in citrus fruits, reduces TAFI expression in HepG2 cells through transcriptional inhibition.

Takada K, Seike T, Sasaki T, Masuda Y, Ito A, Ishii H.

Thromb Haemost. 2013 Jun;109(6):1060-9. doi: 10.1160/TH12-08-0597. Epub 2013 Mar 28.

PMID:
23572161
2.

Regulation of the mouse gene encoding TAFI by TNFα: role of NFκB binding site.

Garand M, Lin JH, Hill CE, Zagorac B, Koschinsky ML, Boffa MB.

Cytokine. 2012 Mar;57(3):389-97. doi: 10.1016/j.cyto.2011.11.023. Epub 2012 Jan 2.

PMID:
22217421
3.

The mRNA encoding TAFI is alternatively spliced in different cell types and produces intracellular forms of the protein lacking TAFIa activity.

Lin JH, Novakovic D, Rizzo CM, Zagorac B, Garand M, Filipieva A, Koschinsky ML, Boffa MB.

Thromb Haemost. 2013 Jun;109(6):1033-44. doi: 10.1160/TH12-09-0668. Epub 2013 Apr 18.

PMID:
23595589
4.

PI3-Kinase Inhibitor LY294002 Repressed the Expression of Thrombin-Activatable Fibrinolysis Inhibitor in Human Hepatoma HepG2 Cells.

Masuda Y, Yazawa J, Makino Y, Takada K.

Biol Pharm Bull. 2015;38(10):1529-35. doi: 10.1248/bpb.b15-00295.

5.

Identification of tristetraprolin as a factor that modulates the stability of the TAFI transcript through binding to the 3'-untranslated region.

Novakovic D, Kuo AC, Lin JH, Koschinsky ML, Boffa MB.

J Thromb Haemost. 2012 May;10(5):887-94. doi: 10.1111/j.1538-7836.2012.04689.x.

6.

Acute phase mediators modulate thrombin-activable fibrinolysis inhibitor (TAFI) gene expression in HepG2 cells.

Boffa MB, Hamill JD, Maret D, Brown D, Scott ML, Nesheim ME, Koschinsky ML.

J Biol Chem. 2003 Mar 14;278(11):9250-7.

7.

Peroxisome proliferator-activated receptor-alpha agonists repress expression of thrombin-activatable fibrinolysis inhibitor by decreasing transcript stability.

Masuda Y, Saotome D, Takada K, Sugimoto K, Sasaki T, Ishii H.

Thromb Haemost. 2012 Jul;108(1):74-85. doi: 10.1160/TH12-02-0101. Epub 2012 Apr 26.

PMID:
22535242
8.

Pro-inflammatory cytokines reduce human TAFI expression via tristetraprolin-mediated mRNA destabilisation and decreased binding of HuR.

Komnenov D, Scipione CA, Bazzi ZA, Garabon JJ, Koschinsky ML, Boffa MB.

Thromb Haemost. 2015 Aug;114(2):337-49. doi: 10.1160/TH14-08-0653. Epub 2015 Jun 11.

PMID:
26062599
9.

Molecular analysis of the human thrombin-activatable fibrinolysis inhibitor gene promoter.

Garand M, Bastajian N, Nesheim ME, Boffa MB, Koschinsky ML.

Br J Haematol. 2007 Jul;138(2):231-44.

PMID:
17593031
10.

Regulation of the gene encoding human thrombin-activatable fibrinolysis inhibitor by estrogen and progesterone.

Garand M, Lin JH, Zagorac B, Koschinsky ML, Boffa MB.

Blood Coagul Fibrinolysis. 2013 Jun;24(4):393-404. doi: 10.1097/MBC.0b013e32835d543a.

PMID:
23429253
11.

Identification of human thrombin-activatable fibrinolysis inhibitor in vascular and inflammatory cells.

Lin JH, Garand M, Zagorac B, Schadinger SL, Scipione C, Koschinsky ML, Boffa MB.

Thromb Haemost. 2011 Jun;105(6):999-1009. doi: 10.1160/TH10-06-0413. Epub 2011 Apr 20.

PMID:
21505719
12.

Effect of single nucleotide polymorphisms on expression of the gene encoding thrombin-activatable fibrinolysis inhibitor: a functional analysis.

Boffa MB, Maret D, Hamill JD, Bastajian N, Crainich P, Jenny NS, Tang Z, Macy EM, Tracy RP, Franco RF, Nesheim ME, Koschinsky ML.

Blood. 2008 Jan 1;111(1):183-9. Epub 2007 Sep 12.

13.

Expression of thrombin-activatable fibrinolysis inhibitor (TAFI) is up-regulated by increase in intracellular cyclic AMP levels in cultured HepG2 cells.

Ishii H, Kojima Y, Masuda Y, Takada K, Sugimoto K, Ikeda T.

Thromb Haemost. 2009 Dec;102(6):1204-11. doi: 10.1160/TH09-03-0194.

PMID:
19967152
14.

Sp1 is an essential transcription factor for LPS-induced tissue factor expression in THP-1 monocytic cells, and nobiletin represses the expression through inhibition of NF-kappaB, AP-1, and Sp1 activation.

Hirata Y, Masuda Y, Kakutani H, Higuchi T, Takada K, Ito A, Nakagawa Y, Ishii H.

Biochem Pharmacol. 2008 Apr 1;75(7):1504-14. doi: 10.1016/j.bcp.2007.12.019. Epub 2008 Jan 5.

PMID:
18261712
15.

A role for CCAAT/enhancer-binding protein in hepatic expression of thrombin-activable fibrinolysis inhibitor.

Boffa MB, Hamill JD, Bastajian N, Dillon R, Nesheim ME, Koschinsky ML.

J Biol Chem. 2002 Jul 12;277(28):25329-36. Epub 2002 May 8.

17.

Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B).

Boffa MB, Reid TS, Joo E, Nesheim ME, Koschinsky ML.

Biochemistry. 1999 May 18;38(20):6547-58.

PMID:
10350473
18.
19.
20.

[Thrombin activatable fibrinolysis inhibitor (TAFI) and its importance in the regulation of fibrinolysis].

Stasko J, Hudecek J, Kubisz P.

Vnitr Lek. 2004 Jan;50(1):36-44. Review. Slovak.

PMID:
15015228

Supplemental Content

Support Center